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Tuberculosis (TB) is one of the largest single infectious
causes of death worldwide.1 Susceptibility to TB is influ-
enced by host genetic factors.2 The vitamin D receptor (VDR)
is an area of interest related to genetic polymorphisms
associated with TB.
The active metabolite of vitamin D, 1,25-dihydroxyvi-
tamin D3, is an important immunomodulatory hormone that
enhances phagocytosis via the activation of macrophages.
Vitamin D3 has also been shown to restrict the growth of
Mycobacterium tuberculosis in macrophages.3 Recent stu-
dies have indicated many polymorphisms to exist in the
vitamin D receptor (VDR) gene, but the influence of VDR
gene polymorphisms on VDR protein function and signaling
is largely unknown. So far, three adjacent restriction
fragment length polymorphisms for FokI, BsmI, and TaqI,
at the VDR gene have been studied most frequently.
FokI (424 and 427 amino acid variants) appears to be
functional, and the 424aa variant is more active in terms
of transactivation capacity. However, BsmI and TaqI are in
linkage disequilibrium with the 30-untranslated region
(30UTR) and functionality is currently assumed to be due
to this.4
Although the role of VDR polymorphisms in TB has been
evaluated in several studies, results have been inconsistent.
In order to gain a better understanding of the role of VDR
polymorphism in TB susceptibility, we examined the poly-
morphisms of the VDR gene in Iranian TB patients.
A total of 60 unrelated patients of Iranian ancestry with
confirmed pulmonary TB (PTB) were evaluated in this study.
Patients were enrolled from Massih Daneshvari Hospital, a TB
referral center in Iran, from February to August 2005. A
control group consisted of 62 healthy subjects selected
randomly from blood donor centers close to the reported
residences of the 60 cases.
Exclusion criteria for both case and control groups were:
concurrent disease predisposing to TB (e.g., HIV/AIDS, dia-
betes mellitus, liver cirrhosis, chronic renal failure), use of
immunosuppressive drugs and organ transplantation, and
malignancy with the exception of basal cell carcinoma.
Additionally, potential controls were excluded if the patient
had a past history of TB. In agreement with the protocols1201-9712/$36.00 # 2009 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2009.05.001approved by the Institutional Review Board, written consent
was obtained from all participants.
For each patient, 10 ml of blood was drawn and stored.
VDR genotyping of FokI, BsmI, and TaqI polymorphisms was
carried out by PCR amplification using the genomic DNA of the
patients and normal subjects and specific primers as pre-
viously described.5 All data were statistically analyzed with
SPSS version 15.0 (SPSS Inc., Chicago, IL, USA).
The mean  standard deviation age of the TB group was
45.8  11 years and the control group was 41  9 years
( p = 0.74); 30 (50%) of the TB group and 36 (58%) of the
control subjects were male ( p = 0.38).
Table 1 summarizes allele and genotype frequencies of
FokI, BsmI, and TaqI polymorphisms of VDR pulmonary TB and
control subjects.
The main findings of our study are: (1) the FokI locus of the
VDR gene is not associated with either susceptibility or
resistance to TB in this study population; (2) genotypes BB
from BsmI and TT from TaqI locus occur at a significantly
lower frequency in TB patients; (3) genotypes bb from BsmI
and tt from TaqI locus occur at a much higher frequency in TB
patients.
We did not find a direct association between the VDR FokI
polymorphism and the propensity to develop active TB.
However, Liu et al.6 showed that FokI-ff homozygotes
occurred more frequently in TB patients as compared to
the control group in a study conducted in China
(OR = 2.18). In agreement with our finding, several other
published studies have failed to reveal any effect of FokI
on TB.7,8
In one of the few studies on BsmI polymorphism and TB,
Bornman et al.,9 in a West African study, demonstrated that
the relationship between the two is nonexistent. In contrast,
our results revealed a strong association between bb geno-
type and TB irrespective of patient gender (OR = 5.7). More-
over, the BB genotype was found to be associated with
resistance to PTB in our study (OR = 0.28). Selvaraj et al.10
also showed genotype BB in Indian males to be associated
with resistance to PTB.
People with VDR genotype tt were underrepresented in
the TB group in the study conducted by Bellamy et al.3 A
previous study, however, showed that patients with severe
PTB had a trend towards a lower frequency of the tt genotype
in Gambia. Delgado et al.11 demonstrated an opposing result,
concluding that the TaqI genotype has no effect on suscept-
ibility to TB.Published by Elsevier Ltd. All rights reserved.
Table 1 Genotype frequencies of FokI, BsmI, and TaqI polymorphisms of VDR pulmonary TB and control subjects
VDR polymorphism Genotype frequency p-Values OR (95% CI)
TB patients (N = 60) Controls (N = 62)
Genotype n (%) n (%)
FokI FF 30 (50) 29 (47) 0.72 1.14 (0.56—2.32)
Ff 21 (35) 27 (43) 0.34 0.70 (0.35—1.45)
ff 9 (15) 6 (10) 0.37 1.65 (0.55—4.95)
BsmI BB 13 (22) 31 (50) 0.001 0.28 (0.13—0.61)
Bb 27 (45) 26 (42) 0.73 1.13 (0.55—2.32)
bb 20 (33) 5 (8) < 0.0001 5.7 (1.98—16.45)
TaqI TT 8 (13) 33 (53) < 0.0001 0.135 (0.06—0.33)
Tt 33 (55) 24 (39) 0.07 1.94 (0.94—3.98)
tt 19 (32) 5 (8) 0.001 5.3 (1.82—15.30)
VDR, vitamin D receptor; TB, tuberculosis; OR, odds ratio; CI, confidence interval.
Letter to the Editor e85Our study has some limitations. First, the sample size is
small for a high power genetic susceptibility study. Second,
the results could have been strengthened by the inclusion of
purified protein derivative results and bacille Calmette—
Gue´rin history in the case and control groups.
In summary, this study found significant differences in the
frequency of BsmI and TaqI haplogroups of VDR between PTB
patients and the healthy control population. Our data sup-
port the link between vitamin D receptor alteration and
susceptibility to TB. Further research is needed to better
characterize this association and to evaluate its clinical
significance in TB prevention and control.
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